Episode Details

In this episode, we discuss the FDA approval process, the impact of Pharmaceutical influence, and how this affects lithium's underutilization.  We talk about Industry-sponsored vs NIH studies and the problems with not publishing negative data.  Finally, Dr. El-Mallakh and I go back and forth trying to find some middle ground in our opinions by weighing the benefits of pharmaceutical influence with the risks of poor regulatory practices.

Thanks for listening.  For more social media content, check us out on all social media platforms @Renegadepsych. If you have any comments, questions or challenges to the information we've presented here, if you'd like to be a guest to the show, or if you have general comments, questions, or suggestions, email us at Renegadepsych@gmail.com and follow the link https://renegade-psych.podcastpage.io/ to our website for source material, transcripts, and additional links for my guests. If you feel passionate about our message and what we're trying to do, and you'd like to donate, you can also follow the link in the show notes to our website.

Disclaimer, this podcast is for informational purposes only. The information provided in this podcast and related materials are meant only to educate.  This information is not intended as a substitute for professional medical advice. While I am a medical doctor and many of my guests have extensive medical training and experience, nothing stated in this podcast nor materials related to this podcast, including recommended websites, texts, graphics, images, or any other materials should be treated as a substitute for professional medical or psychological advice, diagnosis or treatment. All listeners should consult with a medical professional, licensed mental health provider or other healthcare provider if seeking medical advice, diagnosis, or treatment.